Price: $399.99
Duration: 30 Months of Access
Deliverables: 12 Hours of AAPA Category 1 Pharmacology CME
Bonus: Amazon or Apple Gift Card add-on options available ($100–$1500)
Maintaining prescriptive authority is a critical logistical requirement for both Physician Assistants (PAs) and Nurse Practitioners (NPs). State boards and national certification bodies mandate specific pharmacology continuing medical education (CME) hours to ensure safe prescribing practices, particularly concerning controlled substances and modern pharmacotherapeutics.
Our Pharmacology CME Review Package provides 12 hours of AAPA Category 1 Pharmacology credit designed to meet these specific regulatory needs efficiently.
Prescriptive Authority Requirements for PAs and NPs
Regulatory requirements for prescriptive authority vary by state, but the core need for pharmacology-specific education remains constant.
For Physician Assistants (PAs)
PAs must complete 100 CME credits every two years to maintain NCCPA certification, with at least 50 credits being Category 1. However, state medical boards often impose additional requirements for prescriptive authority. Many states require a specific number of Category 1 hours in pharmacology or controlled substance prescribing for the initial application and subsequent renewals of a DEA license.
The AAPA Category 1 Pharmacology credits offered in our course are recognized by state boards across the country as valid fulfillment of these requirements.
For Nurse Practitioners (NPs)
While NPs are typically governed by state Boards of Nursing (BON), AAPA Category 1 credit is widely accepted. The American Academy of Nurse Practitioners Certification Board (AANPCB) and the American Nurses Credentialing Center (ANCC) recognize AAPA Category 1 CME as valid continuing education for recertification.
Many states require NPs to complete 10 to 24 contact hours of pharmacology or pharmacotherapeutics CE to maintain their prescriptive authority. Utilizing our 12-hour Pharmacology course is a direct method to satisfy these hours while gaining clinical insights into modern drug therapy.
Efficient CME Allocation: PANRE Review and Gift Cards
If your requirements extend beyond pharmacology, the PANRE Review Course offers a more comprehensive credit package.
- PANRE Review Course: Provides 100 hours of AAPA Category 1 credit. This is the most efficient way to satisfy your entire two-year NCCPA Category 1 requirement in a single course.
- CME with Gift Cards: We offer the ability to add Amazon or Apple gift cards ranging from $100 to $1500 to your purchase. This allows you to utilize your employer-provided CME budget to acquire both the necessary credits and tools to further your education, such as medical texts or technology.
Our content covers essential clinical areas including Emergency Medicine, Family Medicine, Internal Medicine, Orthopedics, Dermatology, Psychiatry, Neurology, Cardiology, and OB/GYN. While written by PAs for PAs, the clinical depth provides significant value for NPs and physicians (who can claim Category 2 credit).
Clinical Assessment: Pharmacology and Management
The following clinical scenario tests your knowledge of pharmacotherapeutics and management in a primary care setting.
Patient Scenario
Your patient is a 64-year-old male with a history of hypertension, Type 2 Diabetes Mellitus, and chronic kidney disease (Stage 3, GFR 42 mL/min/1.73m²). He presents for a follow-up regarding his blood pressure. Current medications include Metformin 1000mg BID and Lisinopril 200mg daily. Today, his blood pressure is 152/94 mmHg (confirmed by repeat measurement). His electrolytes are within normal limits, but his serum potassium is at the high end of normal (5.1 mEq/L).
Which of the following is the most appropriate next step in the pharmacological management of this patient's hypertension?
A) Increase Lisinopril to 40mg daily
B) Add Spironolactone 25mg daily
C) Add Amlodipine 5mg daily
D) Discontinue Lisinopril and start Losartan 50mg daily
Explanation
Correct Answer: C) Add Amlodipine 5mg daily
In patients with chronic kidney disease (CKD) and diabetes, the goal blood pressure is typically <130/80 mmHg. While ACE inhibitors like Lisinopril are first-line for renal protection, this patient is already on a standard dose, and his potassium is 5.1 mEq/L. Amlodipine, a calcium channel blocker, is the most appropriate addition because it effectively lowers blood pressure without the risk of hyperkalemia associated with increasing ACE inhibitor doses or adding a potassium-sparing diuretic like Spironolactone.
- A is incorrect because increasing the Lisinopril dose in a patient with a baseline potassium of 5.1 mEq/L and Stage 3 CKD increases the risk of significant hyperkalemia.
- B is incorrect because Spironolactone is a potassium-sparing diuretic. Adding it to an ACE inhibitor in a patient with a potassium of 5.1 mEq/L and impaired renal function is contraindicated due to the high risk of life-threatening hyperkalemia.
- D is incorrect because switching from an ACE inhibitor (Lisinopril) to an ARB (Losartan) does not provide additional blood pressure lowering and carries similar risks regarding potassium and renal function; it is generally not recommended to combine or switch between these classes unless the patient develops a cough from the ACE inhibitor.
Summary of Credit Availability
- PANRE Review Course: 100 Hours of AAPA Category 1 Credit.
- Pharmacology Review Course: 12 Hours of AAPA Category 1 Pharmacology Credit.
- Access: All courses include 30 months of access.
- Add-ons: Gift cards available up to $1500.
For PAs and NPs looking to fulfill state-specific prescriptive authority requirements or national recertification needs, our pharmacology and PANRE review options provide a high-yield, accredited solution. Avoid the logistical hurdle of piecing together smaller credits and secure your professional standing with our comprehensive packages.